{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:01:04Z","timestamp":1777658464861,"version":"3.51.4"},"reference-count":61,"publisher":"Akademiai Kiado Zrt.","issue":"1","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Hungarian National Research, Development and Innovation Office","award":["KKP126835"],"award-info":[{"award-number":["KKP126835"]}]}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["JBA"],"published-print":{"date-parts":[[2024,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gambling disorder is a severe mental health and behavioural problem with harmful consequences, including financial, relationship and mental health problems. The present paper initiates discussion on the use of psychedelics combined with psychotherapeutic support as a potential treatment option for people living with a gambling disorder. Recent studies have shown promising results using psychedelic-assisted therapy (PAT) to treat anxiety, depression, post-traumatic stress disorder, and various substance use disorders. Considering the similarities in the underlying psychosocial and neurobiological mechanisms of gambling disorder and other addictive disorders, the authors suggest that psychedelic-assisted therapy could be effective in treating gambling disorder. The paper also underscores the need for further research into the viability and effectiveness of psychedelic-assisted therapy for gambling disorder.<\/jats:p>","DOI":"10.1556\/2006.2024.00004","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:33:22Z","timestamp":1711553602000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":8,"title":["Psychedelic-assisted therapy for people with gambling disorder?"],"prefix":"10.1556","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7703-6003","authenticated-orcid":true,"given":"Pedro","family":"Romero","sequence":"first","affiliation":[{"name":"Centre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar, Gibraltar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-0524","authenticated-orcid":true,"given":"Andrea","family":"Czak\u00f3","sequence":"additional","affiliation":[{"name":"Centre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar, Gibraltar"},{"name":"Institute of Psychology, ELTE E\u00f6tv\u00f6s Lor\u00e1nd University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8301-0121","authenticated-orcid":true,"given":"Wim","family":"van den Brink","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Centers, Department of Psychiatry, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5604-7551","authenticated-orcid":true,"given":"Zsolt","family":"Demetrovics","sequence":"additional","affiliation":[{"name":"Centre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar, Gibraltar"},{"name":"Institute of Psychology, ELTE E\u00f6tv\u00f6s Lor\u00e1nd University, Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"B1","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013). In Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). American Psychiatric Association."},{"issue":"2","key":"B2","series-title":"Acta Psychiatrica Scandinavica","first-page":"101","article-title":"Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies","volume":"143","author":"Andersen, K. A. A.","year":"2021","unstructured":"Andersen, K. A. A., Carhart-Harris, R., Nutt, D. J., & Erritzoe, D. (2021). Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatrica Scandinavica, 143(2), 101\u2013118. https:\/\/doi.org\/10.1111\/acps.13249."},{"issue":"61","key":"B3","series-title":"The Journal of Clinical Psychiatry","first-page":"5","article-title":"An overview of side effects caused by typical antipsychotics","author":"Arana, G.","year":"2000","unstructured":"Arana, G. (2000). An overview of side effects caused by typical antipsychotics. The Journal of Clinical Psychiatry, (61 8), 5\u201313."},{"issue":"1","key":"B4","series-title":"Neuroscience of Consciousness","first-page":"niy008","article-title":"Dimensions of consciousness and the psychedelic state","volume":"2018","author":"Bayne, T.","year":"2018","unstructured":"Bayne, T., & Carter, O. (2018). Dimensions of consciousness and the psychedelic state. Neuroscience of Consciousness, 2018(1), niy008. https:\/\/doi.org\/10.1093\/nc\/niy008."},{"issue":"11","key":"B5","series-title":"European Neuropsychopharmacology","first-page":"1443","article-title":"Side effects of antidepressants during long-term use in a naturalistic setting","volume":"23","author":"Bet, P. M.","year":"2013","unstructured":"Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., & Hoogendijk, W. J. G. (2013). Side effects of antidepressants during long-term use in a naturalistic setting. European Neuropsychopharmacology, 23(11), 1443\u20131451. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.001."},{"issue":"10","key":"B6","series-title":"JAMA Psychiatry","first-page":"953","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: A\u00a0randomized clinical trial","volume":"79","author":"Bogenschutz, M. P.","year":"2022","unstructured":"Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., \u2026 Worth, L. (2022). Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: A\u00a0randomized clinical trial. JAMA Psychiatry, 79(10), 953. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.2096."},{"key":"B7","series-title":"Neuropharmacology","first-page":"167","article-title":"The entropic brain\u2014Revisited","volume":"142","author":"Carhart-Harris, R.","year":"2018","unstructured":"Carhart-Harris, R. (2018). The entropic brain\u2014Revisited. Neuropharmacology, 142, 167\u2013178. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.03.010."},{"issue":"4","key":"B8","series-title":"Brain","first-page":"1265","article-title":"The default-mode, ego-functions and free-energy: A neurobiological account of Freudian ideas","volume":"133","author":"Carhart-Harris, R. L.","year":"2010","unstructured":"Carhart-Harris, R. L., & Friston, K. J. (2010). The default-mode, ego-functions and free-energy: A neurobiological account of Freudian ideas. Brain, 133(4), 1265\u20131283. https:\/\/doi.org\/10.1093\/brain\/awq010."},{"issue":"3","key":"B9","series-title":"Pharmacological Reviews","first-page":"316","article-title":"REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris, R. L.","year":"2019","unstructured":"Carhart-Harris, R. L., & Friston, K. J. (2019). REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews, 71(3), 316\u2013344. https:\/\/doi.org\/10.1124\/pr.118.017160."},{"issue":"11","key":"B10","series-title":"Neuropsychopharmacology","first-page":"2105","article-title":"The therapeutic potential of psychedelic drugs: Past, present, and future","volume":"42","author":"Carhart-Harris, R. L.","year":"2017","unstructured":"Carhart-Harris, R. L., & Goodwin, G. M. (2017). The therapeutic potential of psychedelic drugs: Past, present, and future. Neuropsychopharmacology, 42(11), 2105\u20132113. https:\/\/doi.org\/10.1038\/npp.2017.84."},{"key":"B11","series-title":"Frontiers in Human Neuroscience","article-title":"The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris, R.","year":"2014","unstructured":"Carhart-Harris, R., Leech, R., Hellyer, P., Shanahan, M., Feilding, A., Tagliazucchi, E., \u2026 Nutt, D. (2014). The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience, 8. https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2014.00020."},{"issue":"1","key":"B12","series-title":"Neurosciences and History","first-page":"28","article-title":"Psychoactive plants in ancient Greece","volume":"1","author":"Carod-Artal, F. J.","year":"2013","unstructured":"Carod-Artal, F. J. (2013). Psychoactive plants in ancient Greece. Neurosciences and History, 1(1), 28\u201338."},{"issue":"2","key":"bib59","series-title":"European Addiction Research","first-page":"90","article-title":"Problem gambling in the UK: Implications for health, psychosocial adjustment and health care utilization","volume":"22","author":"Cowlishaw, S.","year":"2016","unstructured":"Cowlishaw, S., & Kessler, D. (2016). Problem gambling in the UK: Implications for health, psychosocial adjustment and health care utilization. European Addiction Research, 22(2), 90\u201398. https:\/\/doi.org\/10.1159\/000437260."},{"issue":"2","key":"B13","series-title":"American Journal of Psychiatry","first-page":"125","article-title":"A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: A randomized Midazolam-controlled pilot trial","volume":"177","author":"Dakwar, E.","year":"2020","unstructured":"Dakwar, E., Levin, F., Hart, C. L., Basaraba, C., Choi, J., Pavlicova, M., & Nunes, E. V. (2020). A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: A randomized Midazolam-controlled pilot trial. American Journal of Psychiatry, 177(2), 125\u2013133. https:\/\/doi.org\/10.1176\/appi.ajp.2019.19070684."},{"issue":"5","key":"B14","series-title":"JAMA Psychiatry","first-page":"481","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: A\u00a0randomized clinical trial","volume":"78","author":"Davis, A. K.","year":"2021","unstructured":"Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., \u2026 Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A\u00a0randomized clinical trial. JAMA Psychiatry, 78(5), 481. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.3285."},{"issue":"4","key":"B15","series-title":"Nature Medicine","first-page":"4","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws, R. E.","year":"2022","unstructured":"Daws, R. E., Timmermann, C., Giribaldi, B., Sexton, J. D., Wall, M. B., Erritzoe, D., \u2026 Carhart-Harris, R. (2022). Increased global integration in the brain after psilocybin therapy for depression. Nature Medicine, 28(4), 4. https:\/\/doi.org\/10.1038\/s41591-022-01744-z."},{"key":"B16","series-title":"Frontiers in Psychiatry","article-title":"Psychedelics and neuroplasticity: A systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"de Vos, C. M. H.","year":"2021","unstructured":"de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021). Psychedelics and neuroplasticity: A systematic review unraveling the biological underpinnings of psychedelics. Frontiers in Psychiatry, 12. https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.724606."},{"issue":"6","key":"B17","series-title":"International Clinical Psychopharmacology","first-page":"287","article-title":"The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: A\u00a0review","volume":"28","author":"Dols, A.","year":"2013","unstructured":"Dols, A., Sienaert, P., van Gerven, H., Schouws, S., Stevens, A., Kupka, R., & Stek, M. L. (2013). The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: A\u00a0review. International Clinical Psychopharmacology, 28(6), 287\u2013296. https:\/\/doi.org\/10.1097\/YIC.0b013e32836435e2."},{"key":"B18","series-title":"Pharmacological Reviews","first-page":"982","article-title":"Self-entropic broadening theory: Toward a new understanding of self and behavior change informed by psychedelics and psychosis","volume":"74","author":"Dourron, H.","year":"2022","unstructured":"Dourron, H., Strauss, C., & Hendricks, P. (2022). Self-entropic broadening theory: Toward a new understanding of self and behavior change informed by psychedelics and psychosis. Pharmacological Reviews, 74, 982\u20131027. https:\/\/doi.org\/10.1124\/pharmrev.121.000514."},{"issue":"6","key":"bib60","series-title":"Australian & New Zealand Journal of Psychiatry","first-page":"519","article-title":"Prevalence of psychiatric co-morbidity in treatment-seeking problem gamblers: A systematic review and meta-analysis","volume":"49","author":"Dowling, N. A.","year":"2015","unstructured":"Dowling, N. A., Cowlishaw, S., Jackson, A. C., Merkouris, S. S., Francis, K. L., & Christensen, D. R. (2015). Prevalence of psychiatric co-morbidity in treatment-seeking problem gamblers: A systematic review and meta-analysis. Australian & New Zealand Journal of Psychiatry, 49(6), 519\u2013539. https:\/\/doi.org\/10.1177\/0004867415575774."},{"issue":"3","key":"B19","series-title":"Journal of Behavioral Addictions","first-page":"613","article-title":"Psychological intervention for gambling disorder: A systematic review and meta-analysis","volume":"12","author":"Eriksen, J. W.","year":"2023","unstructured":"Eriksen, J. W., Fiskaali, A., Zachariae, R., Wellnitz, K. B., Oernboel, E., Stenbro, A. W., \u2026 Petersen, M. W. (2023). Psychological intervention for gambling disorder: A systematic review and meta-analysis. Journal of Behavioral Addictions, 12(3), 613\u2013630. https:\/\/doi.org\/10.1556\/2006.2023.00034."},{"issue":"3","key":"B20","series-title":"Psychiatry (Edgmont)","first-page":"22","article-title":"The biopsychosocial consequences of pathological gambling","volume":"2","author":"Fong, T. W.","year":"2005","unstructured":"Fong, T. W. (2005). The biopsychosocial consequences of pathological gambling. Psychiatry (Edgmont), 2(3), 22\u201330."},{"issue":"2","key":"B21","series-title":"Journal of Behavioral Addictions","first-page":"267","article-title":"Differences in problem and pathological gambling: A narrative review considering sex and gender","volume":"11","author":"Gartner, C.","year":"2022","unstructured":"Gartner, C., Bickl, A., H\u00e4rtl, S., Loy, J. K., & H\u00e4ffner, L. (2022). Differences in problem and pathological gambling: A narrative review considering sex and gender. Journal of Behavioral Addictions, 11(2), 267\u2013289. https:\/\/doi.org\/10.1556\/2006.2022.00019."},{"issue":"18","key":"B22","series-title":"New England Journal of Medicine","first-page":"1637","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin, G. M.","year":"2022","unstructured":"Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., \u2026 Malievskaia, E. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. New England Journal of Medicine, 387(18), 1637\u20131648. https:\/\/doi.org\/10.1056\/NEJMoa2206443."},{"issue":"1","key":"B23","series-title":"The Primary Care Companion for CNS Disorders","article-title":"Response of refractory gambling disorder to intravenous ketamine","volume":"22","author":"Grant, J. E.","year":"2020","unstructured":"Grant, J. E., & Chamberlain, S. R. (2020). Response of refractory gambling disorder to intravenous ketamine. The Primary Care Companion for CNS Disorders, 22(1), 23062. https:\/\/doi.org\/10.4088\/PCC.19l02480."},{"key":"B24","series-title":"PsyArXiv","article-title":"The yale manual for psilocybin-assisted therapy of depression (using acceptance and commitment therapy as a therapeutic frame)","author":"Guss, J.","year":"2020","unstructured":"Guss, J., Krause, R., & Sloshower, J. (2020). The yale manual for psilocybin-assisted therapy of depression (using acceptance and commitment therapy as a therapeutic frame). PsyArXiv. https:\/\/doi.org\/10.31234\/osf.io\/u6v9y."},{"key":"B25","series-title":"Pharmacological management of gambling disorder: A systematic review and Network meta-analysis (p. 2023.10.20.23297314)","author":"Ioannidis, K.","year":"2023","unstructured":"Ioannidis, K., Giovane, C. D., Tzagarakis, C., Solly, J. E., Westwood, S. J., Parlatini, V., \u2026 Chamberlain, S. R. (2023). Pharmacological management of gambling disorder: A systematic review and Network meta-analysis (p. 2023.10.20.23297314). medRxiv. https:\/\/doi.org\/10.1101\/2023.10.20.23297314."},{"key":"B26","series-title":"Disruptive psychopharmacology","first-page":"213","article-title":"Classic psychedelics in addiction treatment: The case for psilocybin in tobacco smoking cessation","volume":"Vol. 56","author":"Johnson, M. W.","year":"2022","unstructured":"Johnson, M. W. (2022). Classic psychedelics in addiction treatment: The case for psilocybin in tobacco smoking cessation. In F. S. Barrett, & K. H. Preller (Eds.), Disruptive psychopharmacology (Vol. 56, pp. 213\u2013227). Springer International Publishing. https:\/\/doi.org\/10.1007\/7854_2022_327."},{"issue":"11","key":"B27","series-title":"Journal of Psychopharmacology","first-page":"983","article-title":"Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson, M. W.","year":"2014","unstructured":"Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983\u2013992. https:\/\/doi.org\/10.1177\/0269881114548296."},{"issue":"1","key":"B28","series-title":"The American Journal of Drug and Alcohol Abuse","first-page":"55","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson, M. W.","year":"2017","unstructured":"Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017). Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse, 43(1), 55\u201360. https:\/\/doi.org\/10.3109\/00952990.2016.1170135."},{"issue":"4","key":"B29","series-title":"Journal of Behavioral Addictions","first-page":"1091","article-title":"Gambling disorder, increased mortality, suicidality, and associated comorbidity: A\u00a0longitudinal nationwide register study","volume":"7","author":"Karlsson, A.","year":"2018","unstructured":"Karlsson, A., & H\u00e5kansson, A. (2018). Gambling disorder, increased mortality, suicidality, and associated comorbidity: A\u00a0longitudinal nationwide register study. Journal of Behavioral Addictions, 7(4), 1091\u20131099. https:\/\/doi.org\/10.1556\/2006.7.2018.112."},{"issue":"12","key":"B30","series-title":"Journal of Psychopharmacology","first-page":"1212","article-title":"The role of psychedelics in palliative care reconsidered: A case for psilocybin","volume":"30","author":"Kelmendi, B.","year":"2016","unstructured":"Kelmendi, B., Corlett, P., Ranganathan, M., D\u2019Souza, C., & Krystal, J. H. (2016). The role of psychedelics in palliative care reconsidered: A case for psilocybin. Journal of Psychopharmacology, 30(12), 1212\u20131214. https:\/\/doi.org\/10.1177\/0269881116675781."},{"issue":"9","key":"B31","series-title":"Psychological Medicine","first-page":"1351","article-title":"DSM-IV pathological gambling in the national comorbidity survey replication","volume":"38","author":"Kessler, R. C.","year":"2008","unstructured":"Kessler, R. C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N. A., Winters, K. C., & Shaffer, H. J. (2008). DSM-IV pathological gambling in the national comorbidity survey replication. Psychological Medicine, 38(9), 1351\u20131360. https:\/\/doi.org\/10.1017\/S0033291708002900."},{"issue":"7","key":"B32","series-title":"Journal of Psychopharmacology","first-page":"994","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials","volume":"26","author":"Krebs, T. S.","year":"2012","unstructured":"Krebs, T. S., & Johansen, P.-\u00d8. (2012). Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 26(7), 994\u20131002. https:\/\/doi.org\/10.1177\/0269881112439253."},{"key":"B33","series-title":"Neuropsychopharmacology","first-page":"1659","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","volume":"48","author":"Ley, L.","year":"2023","unstructured":"Ley, L., Holze, F., Arikci, D., Becker, A. M., Straumann, I., Klaiber, A., \u2026 Liechti, M. E. (2023). Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Neuropsychopharmacology, 48, 1659\u20131667. https:\/\/doi.org\/10.1038\/s41386-023-01607-2."},{"key":"B34","series-title":"European Psychiatry","first-page":"28","article-title":"Recovery, relapse, or else? Treatment outcomes in gambling disorder from a multicenter follow-up study","volume":"43","author":"M\u00fcller, K. W.","year":"2017","unstructured":"M\u00fcller, K. W., W\u00f6lfling, K., Dickenhorst, U., Beutel, M. E., Medenwaldt, J., & Koch, A. (2017). Recovery, relapse, or else? Treatment outcomes in gambling disorder from a multicenter follow-up study. European Psychiatry, 43, 28\u201334. https:\/\/doi.org\/10.1016\/j.eurpsy.2017.01.326."},{"issue":"6","key":"B35","series-title":"Nature Medicine","article-title":"MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell, J. M.","year":"2021","unstructured":"Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., \u2026 Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6) Article 6 https:\/\/doi.org\/10.1038\/s41591-021-01336-3."},{"key":"B36","article-title":"A manual for MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder","author":"Mithoefer, M. C.","year":"2015","unstructured":"Mithoefer, M. C. (2015). A manual for MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder."},{"issue":"2","key":"B37","series-title":"Journal of Gambling Studies","first-page":"483","article-title":"Risk factors for gambling disorder: A systematic review","volume":"39","author":"Moreira, D.","year":"2023","unstructured":"Moreira, D., Azeredo, A., & Dias, P. (2023). Risk factors for gambling disorder: A systematic review. Journal of Gambling Studies, 39(2), 483\u2013511. https:\/\/doi.org\/10.1007\/s10899-023-10195-1."},{"issue":"2","key":"B38","series-title":"Pharmacological Reviews","first-page":"264","article-title":"Psychedelics","volume":"68","author":"Nichols, D. E.","year":"2016","unstructured":"Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478."},{"key":"B39","series-title":"Nature Medicine","first-page":"1947","article-title":"Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study","volume":"29","author":"Peck, S. K.","year":"2023","unstructured":"Peck, S. K., Shao, S., Gruen, T., Yang, K., Babakanian, A., Trim, J., \u2026 Kaye, W. H. (2023). Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nature Medicine, 29, 1947\u20131953. https:\/\/doi.org\/10.1038\/s41591-023-02455-9."},{"issue":"9","key":"bib58","series-title":"JAMA","first-page":"843","article-title":"Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial","volume":"330","author":"Raison, C. L.","year":"2023","unstructured":"Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., \u2026 Griffiths, R. R. (2023). Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial. JAMA, 330(9), 843\u2013853. https:\/\/doi.org\/10.1001\/jama.2023.14530."},{"key":"B40","series-title":"Substance Abuse and Rehabilitation","first-page":"3","article-title":"A review of gambling disorder and substance use disorders","volume":"7","author":"Rash, C. J.","year":"2016","unstructured":"Rash, C. J., Weinstock, J., & Van Patten, R. (2016). A review of gambling disorder and substance use disorders. Substance Abuse and Rehabilitation, 7, 3\u201313. https:\/\/doi.org\/10.2147\/SAR.S83460."},{"issue":"2","key":"B41","series-title":"Cosmos and History: The Journal of Natural and Social Philosophy","first-page":"2","article-title":"Integrating psilocybin and existential-humanistic psychotherapy for pathological gambling treatment: A new perspective","volume":"15","author":"Re, T.","year":"2019","unstructured":"Re, T., Penazzi, G., Bragazzi, N. L., Khabbache, H., Neri, B., Sim\u00ed\u00b5es, M., \u2026 Firenzuoli, F. (2019). Integrating psilocybin and existential-humanistic psychotherapy for pathological gambling treatment: A new perspective. Cosmos and History: The Journal of Natural and Social Philosophy, 15(2), 2."},{"issue":"1","key":"B42","series-title":"BMC Psychiatry","first-page":"105","article-title":"Non-pharmacological treatment of gambling disorder: A systematic review of randomized controlled trials","volume":"21","author":"Ribeiro, E. O.","year":"2021","unstructured":"Ribeiro, E. O., Afonso, N. H., & Morgado, P. (2021). Non-pharmacological treatment of gambling disorder: A systematic review of randomized controlled trials. BMC Psychiatry, 21(1), 105. https:\/\/doi.org\/10.1186\/s12888-021-03097-2."},{"key":"B43","article-title":"Psilocybin-Assisted Psychotherapy in the Treatment of Gambling Disorder: Rationale and Potential Mechanisms [Poster Presentation] Futures of Gambling Studies","author":"Richard, J\u00e9r\u00e9mie","year":"2023, October 5","unstructured":"Richard, J\u00e9r\u00e9mie & Garcia-Romeu, Albert. (2023, October 5). Psilocybin-Assisted Psychotherapy in the Treatment of Gambling Disorder: Rationale and Potential Mechanisms [Poster Presentation] Futures of Gambling Studies."},{"issue":"1","key":"bib61","series-title":"Journal of Gambling Studies","first-page":"373","article-title":"Mar). Predictors of dropout in disordered gamblers in UK residential treatment","volume":"36","author":"Roberts A.","year":"2020","unstructured":"Roberts A., Murphy R., Turner J., & Sharman S. (2020 Mar). Predictors of dropout in disordered gamblers in UK residential treatment. Journal of Gambling Studies, 36(1), 373\u2013386. https:\/\/doi.org\/10.1007\/s10899-019-09876-7. Erratum in: Journal of Gambling Studies. 2019 Nov 14;: PMID: 31302803; PMCID: PMC7026303."},{"issue":"2","key":"B44","series-title":"Journal of Psychedelic Studies","first-page":"63","article-title":"The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A\u00a0worldwide overview","volume":"3","author":"Samorini, G.","year":"2019","unstructured":"Samorini, G. (2019). The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A\u00a0worldwide overview. Journal of Psychedelic Studies, 3(2), 63\u201380. https:\/\/doi.org\/10.1556\/2054.2019.008."},{"issue":"1","key":"bib57","series-title":"Psychopharmacology","first-page":"15","article-title":"Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: A systematic review","volume":"239","author":"Schimmers, N.","year":"2022","unstructured":"Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W., & Schoevers, R. A. (2022). Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: A systematic review. Psychopharmacology, 239(1), 15\u201333. https:\/\/doi.org\/10.1007\/s00213-021-06027-y."},{"issue":"3","key":"B45","series-title":"Journal of Psychopharmacology","first-page":"258","article-title":"Adverse effects of psychedelics: From anecdotes and misinformation to systematic science","volume":"36","author":"Schlag, A. K.","year":"2022","unstructured":"Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022). Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology, 36(3), 258\u2013272. https:\/\/doi.org\/10.1177\/02698811211069100."},{"key":"B46","series-title":"Plants of the Gods: Their sacred, healing, and hallucinogenic powers","author":"Schultes, R. E.","year":"2001","unstructured":"Schultes, R. E., Hofmann, A., & R\u00e4tsch, C. (2001). Plants of the Gods: Their sacred, healing, and hallucinogenic powers. Inner Traditions\/Bear."},{"issue":"4","key":"B47","series-title":"Journal of Psychopharmacology","first-page":"375","article-title":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder","volume":"35","author":"Sessa, B.","year":"2021","unstructured":"Sessa, B., Higbed, L., O\u2019Brien, S., Durant, C., Sakal, C., Titheradge, D., \u2026 Nutt, D. J. (2021). First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder. Journal of Psychopharmacology, 35(4), 375\u2013383. https:\/\/doi.org\/10.1177\/0269881121991792."},{"issue":"10","key":"B48","series-title":"The Journal of Nervous and Mental Disease","first-page":"577","article-title":"Adverse reactions to psychedelic drugs. A review of the literature","volume":"172","author":"Strassman, R. J.","year":"1984","unstructured":"Strassman, R. J. (1984). Adverse reactions to psychedelic drugs. A review of the literature. The Journal of Nervous and Mental Disease, 172(10), 577\u2013595. https:\/\/doi.org\/10.1097\/00005053-198410000-00001."},{"key":"B49","series-title":"Neuroscience & Biobehavioral Reviews","article-title":"Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review","volume":"140","author":"Van Elk, M.","year":"2022","unstructured":"Van Elk, M., & Yaden, D. B. (2022). Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. Neuroscience & Biobehavioral Reviews, 140, 104793. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104793."},{"issue":"9","key":"B50","series-title":"Nature Reviews Neuroscience","first-page":"642","article-title":"The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders","volume":"11","author":"Vollenweider, F. X.","year":"2010","unstructured":"Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nature Reviews Neuroscience, 11(9), 642\u2013651. https:\/\/doi.org\/10.1038\/nrn2884."},{"key":"B51","series-title":"eClinicalMedicine","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz, R.","year":"2023","unstructured":"von Rotz, R., Schindowski, E. M., Jungwirth, J., Schuldt, A., Rieser, N. M., Zahoranszky, K., \u2026 Vollenweider, F. X. (2023). Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. eClinicalMedicine, 56, 101809. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101809."},{"issue":"1","key":"B52","series-title":"BJPsych Open","first-page":"e19","article-title":"Ketamine for the treatment of mental health and substance use disorders: Comprehensive systematic review","volume":"8","author":"Walsh, Z.","year":"2022","unstructured":"Walsh, Z., Mollaahmetoglu, O. M., Rootman, J., Golsof, S., Keeler, J., Marsh, B., \u2026 Morgan, C. J. A. (2022). Ketamine for the treatment of mental health and substance use disorders: Comprehensive systematic review. BJPsych Open, 8(1), e19. https:\/\/doi.org\/10.1192\/bjo.2021.1061."},{"issue":"5","key":"B53","series-title":"The American Journal of Drug and Alcohol Abuse","first-page":"242","article-title":"Pathological gambling and substance use disorders","volume":"36","author":"Wareham, J. D.","year":"2010","unstructured":"Wareham, J. D., & Potenza, M. N. (2010). Pathological gambling and substance use disorders. The American Journal of Drug and Alcohol Abuse, 36(5), 242\u2013247. https:\/\/doi.org\/10.3109\/00952991003721118."},{"key":"B54","series-title":"The road to eleusis: Unveiling the secret of the mysteries","author":"Wasson, R. G.","year":"2008","unstructured":"Wasson, R. G., Hofmann, A., & Ruck, C. A. P. (2008). The road to eleusis: Unveiling the secret of the mysteries. North Atlantic Books."},{"key":"B55","series-title":"Disruptive psychopharmacology","first-page":"169","article-title":"The potential of psychedelics for end of life and palliative care","author":"Yaden, D. B.","year":"2022","unstructured":"Yaden, D. B., Nayak, S. M., Gukasyan, N., Anderson, B. T., & Griffiths, R. R. (2022). The potential of psychedelics for end of life and palliative care. In F. S. Barrett, & K. H. Preller (Eds.), Disruptive psychopharmacology (pp. 169\u2013184). Springer International Publishing. https:\/\/doi.org\/10.1007\/7854_2021_278."},{"key":"B56","series-title":"Frontiers in Psychiatry","article-title":"Psychedelic therapy in the treatment of addiction: The past, present and future","volume":"14","author":"Zafar, R.","year":"2023","unstructured":"Zafar, R., Siegel, M., Harding, R., Barba, T., Agnorelli, C., Suseelan, S., \u2026 Erritzoe, D. (2023). Psychedelic therapy in the treatment of addiction: The past, present and future. Frontiers in Psychiatry, 14, 1183740. https:\/\/doi.org\/10.3389\/fpsyt.2023.1183740."}],"container-title":["Journal of Behavioral Addictions"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/2006\/13\/1\/article-p6.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/2006\/13\/1\/article-p6.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/2006\/13\/1\/article-p6.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:33:25Z","timestamp":1711553605000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/2006\/13\/1\/article-p6.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":61,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1556\/2006.2024.00004","relation":{},"ISSN":["2062-5871","2063-5303"],"issn-type":[{"value":"2062-5871","type":"print"},{"value":"2063-5303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}